Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is planned to compare the clinical efficacy and safety of aerosolized plus intravenous colistin vs. intravenous colistin as adjunctive therapy for the treatment of ventilator-associated pneumonia (VAP) due to pandrugs-resistant (PDR) Acinetobacter baumannii in the neonates.
Epistemonikos ID: 80e172330f3a6a078adfdb98d9d296d607848d87
First added on: May 17, 2024